Dr. Lauren Penzi, MD

Dr. Penzi practices at New York Dermatology & Mohs Surgery Group in Commack, New York.

Dr. Penzi's NPI, 1720437536, was assigned on June 13, 2016. Dr. Penzi graduated from New York Medical College in 2016. Dr. Penzi holds New York license 308189.

Dr. Penzi's primary practice is New York Dermatology & Mohs Surgery Group, at 353 Veterans Memorial Hwy, Commack, NY 11725 in Suffolk County. The practice phone is (631) 543-4888.

Dr. Penzi's primary practice is New York Dermatology & Mohs Surgery Group in Commack, New York. The medical group on file is MDCS: Manhattan Dermatology and Cosmetic Surgery. Dmand AI also links Dr. Penzi to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Penzi practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Penzi's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Penzi is licensed in New York.

CMS data shows 3,715 Medicare services from Dr. Penzi across 17 procedure codes in 2024, for 733 Medicare patients. Medicare paid $225,164 for them. Every service was in an office.

CMS counts 733 Medicare patients who saw Dr. Penzi in 2024. The largest group is 65 to 74, with 351 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Penzi's median patient age at 62, with 66% women.

In 2024, Dr. Penzi wrote 1,065 Medicare Part D claims for 436 patients. 91% of them were for generic drugs. CMS names the drug for 887 of them, across 22 drugs with 11 or more claims each, at $100,894 in total drug cost. In 2023, CMS named 725 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 66 out of 100 for Dr. Penzi for performance year 2024, reported individually. Dr. Penzi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Penzi as offering telehealth. CMS counts 672 procedures of skin biopsy by Dr. Penzi, more than 97% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin cancer: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Penzi, published from 2017 to 2022. 2017 was the busiest year, with 2. The most frequent topics are Alopecia, Graft vs Host Disease and Scalp. Dr. Penzi has published most often in JAAD Case Rep. Dr. Penzi's most frequent co-authors are Maryanne Makredes Senna, MD, Mariko R. Yasuda, MD and Sarina Berger Elmariah, MD, PhD.

CMS Open Payments shows 348 general payments to Dr. Penzi from 21 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 96% of the total. Abbvie Inc. paid the most, $1,250.

Dr. Penzi graduated from New York Medical College in 2016.